Anti-C1q antibodies and antiendothelial cells antibodies in systemic lupus erythematosus - Relationship with disease activity and renal involvement

Clinical Rheumatology

Volumn 22, Issue 4-5, 2003, Pages 271-278

  Oelzner, Peter ^a   Deliyska, B ^b   Funfstuck R ^a   Hein, G ^a   Herrmann, D ^a   Stein, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Anti Clq antibodies; Antiendothelial cell antibodies; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CELL ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; GLUCOCORTICOID; HYDROXYCHLOROQUINE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; COMPLEMENT HEMOLYSIS TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE DURATION; ELECTROIMMUNOASSAY; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; BIOLOGICAL MARKERS; COHORT STUDIES; COMPLEMENT C1Q; COMPLEMENT C3; COMPLEMENT C4; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0344465905     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0724-3     Document Type: Article

References (44)

1. Swaak AJ, Groenwold J, Bronsveld W (1986) Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 45: 359-366
2. Swaak T, Smeenk R (1987) Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus. Clin Rheumatol 6: 56-73
3. Ho A, Magder LS, Barr SG, Petri M (2001) Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematodes. Arthritis Rheum 44: 2342-2349
4. Suenaga R, Abdou NI (1993) Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis. Clin Exp Immunnol 94: 418-422
5. Tsai CY, Wu TH, Sun KH, Liao TS, Lin WM, Yu CL (1993) Polyclonal IgG anti-dsDNA antibodies exert cytotoxic effect on cultured rat mesangial cells by binding to cell membrane and augmenting apoptosis. Scand J Rheumatol 22: 162-171
6. Lebrun P, Burny W, Cosyns JP, Saint-Remy JM (1994) Injections of complexes made of dsDNA and specific polyclonal antibodies extend MRL 1pr mouse survival: a pilot study. Lupus 3: 47-53
7. Mollnes TE, Haga HJ, Brun JG et al. (1999) Complement activation in patients with systemic lupus erythematosus without nephritis. Rheumatology 38: 933-940
8. Winiesky JJ, Naff GB (1989) Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 32: 1119-1127
9. Coremans IE, Daha MR, van der Voort EA, Muizert Y, Halma C, Breedfeld FC (1992) Antibodies against C1q in anti-glomerular basement membrane nephritis. Clin Exp Immunol. 87: 256-260
10. Coremans IE, Spronk PE, Bootsma H et al. (1995) Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 26: 595-601
11. Gunnarsson I, Ronnelid J, Lundberg I, Jacobson SH (1997) Occurence of anti-C1q-antibodies in IgA nephropathy. Nephrol Dial Transplant 12: 2263-2268
12. Prohaszka Z, Daha MR, Susal C et al. (1999) C1q autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins. Clin Immunol 90: 247-255
13. Horvath L, Czirjak L, Fekete B et al. (2001) Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunol Lett 75: 103-109
14. Tan EM, Cohen AS, Fries JF et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 25: 1271-1277
15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Committee on Prognosis Studies in SLE: Derivation of the SLEDAI (1992) A disease activity index for lupus patients. Arthritis Rheum 35: 630-640
16. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29: 288-291
17. Fremeaux-Bacchi V, Weiss L, Demouchy C, Blouin J, Kazatchkine MD (1996) Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 5: 216-220
18. Norsworthy P, Theodoridis E, Botto M et al. (1999) Over-representation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum 42: 1828-1832
19. Kumar A, Gupta R, Varghese T, Pande RM, Singal RM, Garg OP (1999) Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus. Indian J Med Res 110: 190-193
20. Bernstein KA, Kahl LE, Balow JE, Lefkowith JB (1994) Serologic markers of lupus nephritis in patients: use of a tissue based ELISA and evidence for immunopathogenetic heterogeneity. Clin Exp Immunol 98: 60-65
21. Gunnarsson I, Ronnelid J, Huang YH et al. (1997) Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumatol 36: 32-37
22. Moroni G, Trendelenburg M, Del Papa N et al. (2001) Anti-C1q-antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 37: 490-498
23. Haseley LA, Wisnieski JJ, Denburg MR et al. (1997) Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc gamma RIIA alleles. Kidney Int 52: 1375-1380
24. Bohnsack JF, Tenner AJ, Lauri GW, Kleinman HK, Martin GR, Bro EJ (1985) The C1q subunit of the first component of complement bind laminin: a mechanism for the deposition and retention of immune complexes in basement membrane. Proc Natl Acad Sci USA 82: 3824-3828
25. Mannik M (1987) Mechanisms of tissue deposition of immune complexes. J Rheumatol 14: 35-42
26. Mannik M, Wener MH (1997) Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum 40: 1504-1511
27. Van der Zee JM, Siegert CE, de Vreede TA, Daha MR, Breedveld FC (1991) Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE). Clin Exp Immunol 84: 238-244
28. D'Cruz DP, Houssiau FA, Ramirez G et al. (1991) Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis or vasculitis. Clin Exp Immunol 85: 254-261
29. Cervera R, Khamashta MA, Font J et al. (1992) Anti-endothelial cell antibodies in systemic lupus erythematosus: association with vascular and renal lesions. Med Clin (Barc) 99: 605-608
30. Nylander-Lundqvist E, Back O, Nilsson TK, Rantapaa-Dahlqvist S (1992) Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases. Clin Rheumatol 11: 248-253
31. D'Cruz DP, Wisnieski JJ, Asherson RA, Khamashta MA, Hughes GR (1995) Autoantibodies in systemic lupus erythematosus and urticarial vasculitis. J Rheumatol 22: 1669-1673
32. Chan TM, Cheng IK (1996) A prospective study on anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 78: 41-46
33. Li JS, Liu MF, Lei HY (1996) Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erythematosus: a potential marker for disease activity. Clin Immunol Immunopathol 79: 211-216
34. Navarro M, Cervera R, Font J et al. (1997) Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 6: 521-526
35. Matsuda J, Gotoh M, Gohchi K, Kawasugi K, Tsukamoto M, Saitoh N (1997) Anti-endothelial cell antibodies to the endothelial hybridoma cell line (Eahy926) in systemic lupus erythematosus patients with antiphospholipid antibodies. Br J Haematol 97: 227-232
36. Vismara A, Meroni PL, Tincani A et al. (1998) Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 74: 247-253
37. Hill MB, Phipps JL, Hughes P, Greaves M (1998) Anti-endothelial cell antibodies in primary antiphospholipid syndrome and SLE: patterns of reactivity with membrane antigens on microvascular and umbilical venous cell membranes. Br J Haematol 103: 416-421
38. Rosenbaum J, Pottinger BE, Woo P et al. (1988) Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 72: 450-456
39. Zhang, Y, Geng H, Zhao M, Zou W, Zheng X, Wang H (1999) The significance of anti-endothelial cell antibodies in patients with lupus nephritis and immunoblotting analysis of the target components. Chin Med J 112: 597-602
40. Song J, Park YB, Lee WK, Lee KH, Lee SK (2000) Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 20: 1-7
41. Wang MX, Walker RG, Kincaid-Smith P (1993) Clinicopathologic associations of anti-endothelial cell antibodies in immunoglobulin A nephropathy and lupus nephritis. Am J Kidney Dis 22: 378-386
42. Papa ND, Raschi E, Moroni G, Panzeri P, Borghi MO, Ponticelli C, Tincani A, Balestrieri G, Meroni PL (1999) Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro. Lupus 8: 423-429
43. Carvalho D, Savage CO, Isenberg D, Pearson JD (1999) IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release ot two endothelial cell derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 42: 631-640
44. Yazici ZA, Raschi E, Patel A et al. (2001) Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro. Int Immunol 13: 349-357